PDCD1 and gastric cancer: Several recent studies demonstrate that inhibiting PD-1 is not significantly more effective than chemotherapy (31) and that patients with advanced GC who were administered with PD-1 inhibitors and concurrent chemotherapy have better survival than those who receive chemotherapy alone (32).